Sherbrooke Park Advisers LLC Adma Biologics, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 20,066 shares of ADMA stock, worth $359,382. This represents 0.11% of its overall portfolio holdings.
Number of Shares
20,066
Previous 13,949
43.85%
Holding current value
$359,382
Previous $279 Million
23.42%
% of portfolio
0.11%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$326 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$266 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$202 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.52B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...